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Análise do masseter, por espectroscopia de próton, em pacientes com esclerose
sistêmica
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OBJECTIVE: To evaluate metabolite concentration in the masseter of patients with systemic sclerosis, by
analyzing creatine, choline, lipid and lactate levels, and correlating them with the presence of mandibular
osteolysis. MATERIALS AND METHODS: The sample included 25 individuals, 15 of them with diagnosis of
systemic sclerosis, divided into two groups according to the presence (group I) or absence (group II) of
osteolysis, and 10 healthy individuals (group III, control). All of them were submitted to proton magnetic
resonance spectroscopy with PRESS sequence and 3D acquisition. RESULTS: Metabolite analysis showed
that the creatine and lipid levels were the same for the three groups. Patients in group I presented higher
levels of choline when compared with group III. On the other hand, lower lactate levels were observed in
groups I and II when compared with the healthy individuals. Creatine/lipid and choline/lactate ratios were
the same in the three groups. CONCLUSION: Lower lactate levels were observed in the patients with systemic
sclerosis (groups I and II). Choline levels were increased in the patients with mandibular osteolysis (group I).
Creatine/choline, lipid/lactate and choline/lipid ratios were different among the three groups. Further studies
are necessary to understand the role played by the masseter in the development of mandibular osteolysis.
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OBJETIVO: Avaliar a concentração de metabólitos no masseter em portadores de esclerose sistêmica, ana-
lisando os índices de creatina, colina, lipídio e lactato, e relacionar com a presença de osteólise mandibular.
MATERIAIS E MÉTODOS: Foram selecionados 25 pacientes, sendo 15 com diagnóstico de esclerose sistê-
mica e agrupados de acordo com a presença (grupo I) ou ausência (grupo II) de osteólise, e 10 indivíduos
normais (grupo III, controle). Todos foram submetidos a exame de espectroscopia de próton por ressonância
magnética, com técnica PRESS e aquisição tridimensional. RESULTADOS: O estudo dos metabólitos dos
três grupos apresentou os mesmos valores absolutos de creatina e lipídio. Os pacientes do grupo I apresenta-
ram maior quantidade de colina em relação aos do grupo III. Já os indivíduos dos grupos I e II apresentaram
menor quantidade de lactato em relação aos indivíduos normais. Os índices creatina/lipídio e colina/lactato
foram os mesmos em todos os grupos. CONCLUSÃO: Observamos menor quantidade de lactato nos pacien-
tes com esclerose sistêmica (grupos I e II). A colina está aumentada nos pacientes com osteólise mandibular
(grupo I). Os índices creatina/colina, creatina/lactato, lipídio/lactato e colina/lipídio foram diferentes entre os
grupos estudados. Mais estudos são necessários para a compreensão da participação do masseter no de-
senvolvimento da osteólise mandibular.
Unitermos: Masseter; Esclerose sistêmica; Espectroscopia de próton.
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Raynaud’s phenomenon is usually the
first clinical manifestation among several
clinical findings such as skin thickening(4),
esophageal dysmotility, restrictive pulmo-
nary disease(5–7), pulmonary hypertension,
arthralgias, myopathies, myocardiopathy,
and progressive renal failure(1–3,8).
Musculoskeletal system involvement is
one of the most relevant causes of disabil-
ity in systemic sclerosis(9). Frequently, ero-
sion of the intermediate and terminal por-
tions of the phalanges (acroosteolysis) is
observed, secondary to the involvement of
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sition of collagen and glycosaminoglycans
in the connective tissue of the skin and in-
ternal organs(1–3). This disease has a low in-
cidence disease, affecting 19 individuals
per million inhabitants, with prevalence in
women (3:1). The most affected age group
is between the third and fifth decade of
life(2).
0100-3984 © Colégio Brasileiro de Radiologia e Diagnóstico por Imagem
INTRODUCTION
Systemic sclerosis is a chronic autoim-
mune inflammatory disease of unknown
etiology, characterized by excessive depo-
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the fingertips skin. Less frequently, the sec-
ond and fifth ribs, cervical vertebrae, the
distal portion of the clavicle, radius and
ulna(10,11) are affected.
Systemic sclerosis presents characteris-
tic alterations in the maxillomandibular
complex, such as thickening of periodon-
tal ligament and areas of osteolysis in the
mandible as described by Taveras(12) in
1959, coinciding with the zones of inser-
tion of the lateral pterygoid, temporal and
mainly the masseter muscles. Only a few
studies have evaluated the involvement of
the masseter muscle in systemic sclerosis
as well as the possible association between
this involvement and areas of mandibular
osteolysis by means of electroneuromyo-
graphy(13) and magnetic resonance imaging
(MRI)(14). Based on studies on mandible
microvascularization, Ramón et al.(15) have
proposed that osteolysis originates from
muscle ischemia resulting from microvas-
culopathy typical of systemic sclerosis.
Muscular involvement in systemic scle-
rosis is probably caused by ischemia, which
would lead to an insufficient oxygen and
nutrient supply, inflammation, or to the
sclerotic process itself. Thus, myopathy
would be a primary process of the disease,
and not necessarily resulting from the
superjacent skin involvement(16,17). Studies
about capillary and arteriolar circulation
have shown thickening of the lumen, flow
reduction, stenosis and alterations of the
capillary architecture(18).
The present study was aimed at evalu-
ating the creatine, choline, lipid and lactate
concentrations in the masseter muscle of
patients with systemic sclerosis, by means
of hydrogen spectroscopy, and correlating
the results with the presence of mandibu-
lar osteolysis.
MATERIALS AND METHODS
The present study included 25 male and
female individuals, 15 of them (mean age
= 43.72 ± 7.59 years) with diffuse systemic
sclerosis, and 10 (mean age = 31.82 ± 12.64
years) without the disease forming a con-
trol group. Patients with limited systemic
sclerosis or in association with other rheu-
matic diseases were excluded. The 15 pa-
tients with systemic sclerosis were divided
into two groups — group I, with seven
patients with systemic sclerosis and man-
dibular osteolysis (Figure 1), and group II,
with eight patients with systemic sclerosis
without mandibular osteolysis — and the
group III included the ten healthy individu-
als constituting the control group. The
present study was approved by the Com-
mittee for Ethics in Research, and all the
individuals signed a term of free and in-
formed consent.
All the individuals were submitted to
bilateral MRI study of the masseter (Figure
2) in a 1.5 T Sonata® (Siemens Medical
Figure 1. Panoramic radiography detail showing a
concave area in angle and an ascending branch of
the mandible (arrow), corresponding to osteolytic
area.
Figure 2. Coronal plane, masseter visualization
(arrows) in a patient with systemic sclerosis.
Systems; Erlangen, Germany) equipment
with 40 mT gradient. Turbo spin echo
(TSE) T2-weighted sequences were ac-
quired with relaxation in the coronal plane,
2810 ms repetition time (TR), 84 ms echo
time (TE), number of excitations (NEX) 2,
field of view (FOV) of 230 mm and 5 mm
interval. T1-weighted sequences were ac-
quired with relaxation in the axial plane
(479 ms TR; 13 ms TE; NEX 2; FOV 230
mm; 5 mm interval) with and without fat
suppression (420 ms TR; 13 ms TE; NEX
2; FOV 230 mm; 5 mm interval). Total ac-
quisition time was 15 minutes, and total ex-
amination time was 25 minutes.
Magnetic resonance spectroscopy
(MRS) with PRESS sequence was per-
formed with a 3D-positioned single voxel.
The region of interest (ROI) was repre-
sented by a cubic volume visually posi-
tioned at the central region of the muscle
that anatomically is the site with largest tis-
sue mass (Figure 3). Thus, the frequencies
reading was focused exclusively on the
masseter muscle, without interferences
from surrounding tissues. Values for both
masseters were obtained in groups I and II,
while in group III, the acquisition was uni-
lateral. Only the metabolites related to the
muscle tissue were recorded with the re-
spective frequency scales, in parts per mil-
lion: creatine (3.14), choline (3.30), lactate
(1.14) and lipid (1.42).
The variance analysis (ANOVA) was
utilized for statistical analysis of the me-
tabolites creatine, choline, lipid and lactate
ratios, followed by the Bonferroni or
Tamhane multiple comparisons, as neces-
sary, besides Brown-Forsythe test for
equality of groups variance corrections.
The adopted rejection level for null hypoth-
esis was 0.10 (10%). The software SPSS
11.5 was utilized for statistical analysis.
RESULTS
The values for pure metabolites are
listed on Table 1. The analysis of pure me-
tabolites that can be observed on Table 2,
demonstrated no significant difference re-
garding creatine and lipid among the three
groups. Regarding choline, no significant
difference was observed between patients
with and without osteolysis. The lactate
concentration was lower in patients with
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Figure 3. Coronal, axial and
sagittal planes. Voxel position-
ing on the masseter.
Table 1 Pure metabolites values found in the masseter as related to the groups.
Patient
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
Group
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
III
III
III
III
III
III
III
III
III
III
Creatine
Right
10.60
3.80
1.71
4.41
2.32
9.47
7.89
11.00
6.14
8.42
1.09
2.17
7.26
1.82
13.80
2.70
2.10
9.10
2.80
22.60
3.30
2.40
5.30
3.30
2.90
Left
6.58
4.21
5.27
15.50
46.30
7.03
7.10
10.00
10.80
6.41
0.95
2.81
9.11
2.08
9.64
–
–
–
–
–
–
–
–
–
–
Choline
Right
16.70
6.79
4.06
–6.37
9.56
16.30
11.20
20.98
10.19
15.41
3.85
3.92
11.25
3.81
21.00
2.60
2.90
9.10
3.20
21.60
3.70
2.40
5.40
3.00
3.40
Left
10.24
6.92
11.91
25.42
73.18
12.64
8.73
16.70
15.81
11.99
3.14
6.04
16.02
2.97
19.27
–
–
–
–
–
–
–
–
–
–
Lipid
Right
35.96
8.08
12.70
–22.08
29.78
49.23
31.91
76.29
16.35
22.05
19.70
11.90
29.89
12.23
52.82
11.90
11.90
70.00
24.00
126.00
21.70
12.00
29.00
13.20
13.80
Left
31.60
7.98
41.77
87.14
134.29
27.92
28.52
39.16
35.45
39.25
14.66
11.58
49.79
12.95
71.40
–
–
–
–
–
–
–
–
–
–
Lactate
Right
35.99
12.24
12.66
16.25
44.10
64.56
32.76
62.24
28.07
30.56
7.98
10.60
41.43
8.98
58.35
8.79
7.30
40.20
14.85
44.75
13.56
9.36
11.50
4.80
8.38
Left
26.77
12.30
39.67
80.23
159.75
31.33
19.30
46.61
70.79
30.45
5.93
16.93
41.91
8.10
54.91
–
–
–
–
–
–
–
–
–
–
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systemic sclerosis, with or without osteoly-
sis, as compared with the healthy individu-
als.
The analysis of metabolite ratios dem-
onstrated differences among the groups for
creatine/choline, creatine/lactate, lipid/lac-
tate and choline/lipid (Table 3).
DISCUSSION
MRS was developed early in the nine-
ties, as a noninvasive method for evaluat-
ing metabolites concentration in different
tissues, such as the brain, heart and
muscles(19). This method has been of in-
valuable help for studying the facial
muscles metabolism, considering that con-
ventional methods required biopsies, with
great limitations for this type of study(20).
Proton magnetic resonance spectros-
copy (1H-MRS) was chosen considering
that hydrogen is the most abundant atom in
the organism, with higher sensitivity, easy
performance and interpretation, besides the
capacity to investigate a higher number of
metabolites as compared with phosphorus
spectroscopy (31P-MRS)(21,22).
In the present study, creatine was the
evaluated component of the energy chain.
It acts as a creatine kinase substrate trans-
ferring the phosphate group of the triphos-
phate adenosine molecule to creatine for
the production of phosphocreatine. Phos-
phocreatine, on its turn, is the storing com-
pound utilized for energy production dur-
ing the muscular effort(23). Creatine values
were statistically equivalent in the three
groups, but a previous study with 1H-MRS
found a higher creatine concentration in the
masseter muscle of patients with temporo-
mandibular joint disorder, indicating
higher intensity and/or frequency of bio-
chemical reactions necessary for sustaining
the muscular function(24).
Creatine levels remain stable in the
brain tissue in several diseases(21,23), how-
ever this assertion is not valid for the mus-
culoskeletal system, considering that some
studies about the energy metabolism in
rheumatic diseases have demonstrated vari-
able results. By submitting lower limb
muscles to 31P-MRS, some studies have
observed increased inorganic phosphate/
phosphocreatine levels in patients with
systemic sclerosis and polymyositis(15,25),
which indicates the presence of ischemic
muscle disease. On the other hand, studies
with 1H-MRS have shown a decrease in
creatine concentration in the calf of patients
with eosinophilia-myalgia syndrome(26)
and in patients with Duchenne muscular
dystrophy(27).
As regards to the presence of lactate, the
patients with systemic sclerosis presented
lower concentration than the healthy indi-
viduals. On the other hand, in the present
study no difference was observed between
patients with and without osteolysis. An in
vitro study about muscular metabolism in
Duchenne muscular dystrophy has demon-
strated a decrease in lactate levels in
healthy individuals: the decrease in lactate
concentration indicates a reduction of gly-
colytic activity, or even a decrease in lac-
tate concentration in the muscle(27). In the
present study, the interpretation of this find-
ing can be based on the assumption that the
vascular phenomena related to systemic
sclerosis are not reducing the aerobic ca-
pacity of the masseter because of the ab-
sence of anaerobic glycolysis (lactic acid
system), in the same way that there was no
change in the energy demand (creatine). So,
these phenomena would not significantly
act on the masseter, or would act in a par-
tial way, so that the extensive vascular net-
work of the masseter would, in a way, be
meeting its oxidative energy needs. Then,
both biochemical factors do not appear to
Table 2 Pure metabolite concentration as related to the groups.
Metabolite
Creatine
Choline
Lipid
Lactate
Results
Groups I, II and III presented the same mean values (p = 0.424)
There is a trend of groups I, II and III not presenting the same mean values (p =
0.094)
– Group I = group II (p > 0.999)
– Group I > group III (p = 0.108)
– Group II = group III (p = 0.485)
Groups I, II and III presented the same mean values (p = 0.966)
Groups I, II and III didn’t present the same mean values (p < 0.001)
– Group I = gorup II (p > 0.999)
– Group I < gorup III (p < 0.001)
– Group II < gorup III (p < 0.001)
Table 3 Results from metabolite ratios as related to groups.
Variable
Creatine/choline
Creatine/lipid
Creatine/lactate
Lipid/lactate
Choline/lactate
Choline/lipid
Results
Groups I, II and III didn’t present the same mean values (p < 0.001)
– Group I = group II (p = 0.784)*
– Group I < group III (p < 0.001)*
– Group II < group III (p < 0.001)*
Groups I, II and III presented the same mean values (p = 0.314)
Groups I, II and III didn’t present the same mean values (p = 0.019)†
– Group I = group II (p = 0.423)‡
– Group I = group III (p = 0.355)‡
– Group II < group III (p = 0.040)‡
Groups I, II and III didn’t present the same mean values (p = 0.005)
– Group I = group II (p > 0.999)*
– Group I < group III (p = 0.009)*
– Group II < group III (p = 0.025)*
Groups I, II and III presented the same mean values (p = 0.790)
Groups I, II and III didn’t present the same mean values (p = 0.004)
– Group I = group II (p > 0.999)*
– Group I > group III (p = 0.007)*
– Group II > group III (p = 0.029)*
* Bonferroni multiple comparisons; † Brown-Forsythe correction; ‡ Tamhane multiple comparisons.
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significantly contribute to the osteolysis
genesis, as observed in the present study.
In the same way as creatine, no signifi-
cant difference in lipid levels was observed
among the three groups. Increased lipid
concentration is related to cell degradation
and necrosis(21), and this increase was ob-
served in patients with temporomandibu-
lar joint disorder(24).
Choline was the only metabolite that
showed increased level in healthy individu-
als. The choline level increase reflects a
process of cellular proliferation and evi-
dence of cell membrane synthesis phenom-
ena like those observed in neoplastic dis-
eases, being increased in relation to healthy
muscles(21,28). On the other hand, a decrease
in choline levels may demonstrate abnor-
malities in the membrane, as observed in
patients with Duchenne muscular dystro-
phy(27). Increased choline levels may be
related to cell proliferation and/or increased
density, and besides that, inflammatory
processes may also demonstrate peaks of
this metabolite resulting from the presence
of a large population of inflammatory
cells(28). Thus, the higher choline concen-
tration in patients with osteolysis may be
related to pathophysiological mechanisms
that affect the fibroblast in systemic scle-
rosis(29) and to the growth of conjunctive
tissue in the epimysium and perimysium(1).
Additionally, it was observed that, in sys-
temic sclerosis, one observed that that in
systemic sclerosis the tissue hypoxia in-
duces neoangiogenesis and that there is an
intense proliferation of the vascular intima
layer(30). Therefore, increased choline lev-
els may be a product of the above men-
tioned phenomena, as well as expressing an
inflammatory activity in the masseter
muscle, with these factors as possible par-
ticipants in the genesis of osteolysis.
The metabolites ratios were analyzed to
evaluate their activity as a whole. The cre-
atine/lipid and choline/lactate ratios were
statistically equivalent in the three groups.
On the other hand, the other ratios pre-
sented variances suggesting significance.
Previous studies have showed that choline/
lipid and creatine/lipid ratios are decreased
in patients with polymyositis(26), while in
the present study, an increase was observed
in the choline/lipid ratio and absence of
variation in the creatine/lipid ratio in pa-
tients with systemic sclerosis. Patients with
systemic sclerosis also presented lower cre-
atine/choline and lipid/lactate ratios when
compared with healthy individuals. As re-
gards creatine/lactate ratio, only the pa-
tients without osteolysis showed a decrease
in relation to healthy individuals.
Findings at 1H-MRS should be carefully
interpreted, as they may be a consequence
of interaction of factors such as the disease
activity degree, level of muscle involve-
ment and may even be influenced by medi-
cines such as corticosteroids utilized in the
management of the disease(22). On the other
hand, this method demonstrates biochemi-
cal alterations even in patients with no
clinical or morphological evidence of
muscle alterations(25).
CONCLUSIONS
Lower lactate levels were observed in
the masseter muscle of patients with sys-
temic sclerosis as compared with healthy
individuals, while choline levels tend to be
increased in patients with osteolysis. Cre-
atine/choline, creatine/lactate, lipid/lactate
and choline/lipid ratios showed a trend to-
wards difference among the groups in the
present study. Further studies are necessary
to understand the role played by the mas-
seter in the development of mandibular
osteolysis.
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